Izo2
ActiveSummary
Izo2 has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €75,421 and a net result of €24,286. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 77% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Toutes activités d’ostéopathie,de kinésithérapie,de logopédie,d’ergothérapie,d’orthoptie,de podologie,de manicure et pédicure médicale,de…” (deed in French)
Text of the purpose (deed in French)
“Toutes activités d’ostéopathie,de kinésithérapie,de logopédie,d’ergothérapie,d’orthoptie,de podologie,de manicure et pédicure médicale,de cryothérapie et d’orthopédiste clinique,ainsi que l’exploitation de centres de revalidation autonomes non rattachés à un hôpital et sans hébergement”
- Name clauseThe name the company operates under according to its articles.
- Izo2
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale, organe d’administration” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Organe d’administration, administrateurs non-statutaires révocables ad nutum par l’assemblée générale” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, actions” (deed in French)“Nominatifs, titres autres que les actions” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 12 March at 18:00